| Jan 4, 2025 |
Jan 7, 2025 |
ARROWHEAD PHARMACEUTICALS, INC.
|
COO |
Sell |
97.5
|
+62,816
|
13.53%
|
✓
|
$736.1K |
| Jan 3, 2024 |
Jan 5, 2024 |
ARROWHEAD PHARMACEUTICALS, INC.
|
COO |
Sell |
100.0
|
+51,810
|
12.56%
|
✓
|
$1.1M |
| Jan 5, 2023 |
Jan 6, 2023 |
ARROWHEAD PHARMACEUTICALS, INC.
|
COO |
Sell |
35.0
|
-15,000
|
-3.50%
|
✓
|
$560.9K |
| Jan 3, 2023 |
Jan 5, 2023 |
ARROWHEAD PHARMACEUTICALS, INC.
|
COO |
Sell |
97.5
|
+47,500
|
12.47%
|
✓
|
$670.8K |
| Jan 5, 2022 |
Jan 7, 2022 |
ARROWHEAD PHARMACEUTICALS, INC.
|
General Counsel |
Sell |
40.0
|
-33,300
|
-1.54%
|
✓
|
$2M |
| Feb 8, 2021 |
Feb 10, 2021 |
ARROWHEAD PHARMACEUTICALS, INC.
|
General Counsel |
Sell |
16.3
|
-90,000
|
-23.48%
|
✗
|
$8M |
| Jan 6, 2021 |
Jan 7, 2021 |
ARROWHEAD PHARMACEUTICALS, INC.
|
General Counsel |
Sell |
23.8
|
-25,000
|
-7.85%
|
✓
|
$1.8M |
| Jan 6, 2020 |
Jan 8, 2020 |
ARROWHEAD PHARMACEUTICALS, INC.
|
General Counsel |
Sell |
30.0
|
-14,625
|
-5.36%
|
✓
|
$879.3K |
| May 28, 2019 |
May 29, 2019 |
ARROWHEAD PHARMACEUTICALS, INC.
|
General Counsel |
Sell |
20.0
|
-30,000
|
-12.88%
|
✗
|
$746.4K |
| Jan 18, 2019 |
Jan 18, 2019 |
ARROWHEAD PHARMACEUTICALS, INC.
|
General Counsel |
Sell |
10.0
|
-72,000
|
-23.61%
|
✓
|
$1M |